Once versus twice daily mesalazine to induce remission in paediatric ulcerative colitis: an investigator-initiated randomised controlled trial

被引：0
|
作者：
Turner, D. [1 ]
Yerushalmi, B. [2 ]
Kori, M. [3 ]
Broide, E. [4 ]
Mozer-Glassberg, Y. [5 ]
Shaoul, R. [6 ]
Kolho, K-L [7 ]
Shteyer, E. [8 ]
Shamaly, H. [9 ]
Ledder, O. [10 ]
Cohen, S. [11 ]
Peleg, S. [12 ]
On, A. [13 ]
Levine, A. [14 ]
机构：
[1] Shaare Zedek Med Ctr, Inst Paediat Gastroenterol, Jerusalem, Israel
[2] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[3] Kaplan Hosp, IL-76100 Rehovot, Israel
[4] Asaff Harofeh, Tel Aviv, Israel
[5] Schneiders Children Hosp, Petah Tiqwa, Israel
[6] Rambam Med Ctr, Haifa, Israel
[7] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[8] Hadassah Med Ctr, Kiryat Haddasah, IL-91120 Jerusalem, Israel
[9] French Hosp, Nazareth, Israel
[10] Shaare Zedek Med Ctr, Jerusalem, Israel
[11] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[12] Emek Med Ctr, Afula, Israel
[13] Poria, Tiberias, Israel
[14] Wolfson Med Ctr, Holon, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P623
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [41] Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses
    Kruis, W
    Schreiber, S
    Theuer, D
    Brandes, JW
    Schütz, E
    Howaldt, S
    Krakamp, B
    Hämling, J
    Mönnikes, H
    Koop, I
    Stolte, M
    Pallant, D
    Ewald, U
    GUT, 2001, 49 (06) : 783 - 789
  • [42] One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis
    Hawthorne, A. Barney
    Stenson, Rachel
    Gillespie, David
    Swarbrick, Edwin T.
    Dhar, Anjan
    Kapur, Kapil C.
    Hood, Kerry
    Probert, Chris S. J.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (10) : 1885 - 1893
  • [43] Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial
    Nachum, Z
    Ben-Shlomo, I
    Weiner, E
    Shalev, E
    BRITISH MEDICAL JOURNAL, 1999, 319 (7219): : 1223 - 1227
  • [44] Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
    Reinisch, Walter
    Sandborn, William J.
    Hommes, Daniel W.
    D'Haens, Geert
    Hanauer, Stephen
    Schreiber, Stefan
    Panaccione, Remo
    Fedorak, Richard N.
    Tighe, Mary Beth
    Huang, Bidan
    Kampman, Wendy
    Lazar, Andreas
    Thakkar, Roopal
    GUT, 2011, 60 (06) : 780 - 787
  • [45] An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial
    Connolly, Mark P.
    Nielsen, Sandy K.
    Currie, Craig J.
    Marteau, Philippe
    Probert, Chris S. J.
    Travis, Simon P. L.
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (03): : 168 - 174
  • [46] Once versus twice daily formoterol via Novolizer® for patients with moderate to severe COPD-A double-blind, randomised, controlled trial
    Welte, T.
    Metzenauer, P.
    Hartmann, U.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (01) : 4 - 13
  • [47] Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis
    Kruis, W.
    Jonaitis, L.
    Pokrotnieks, J.
    Mikhailova, T. L.
    Horynski, M.
    Batovsky, M.
    Lozynsky, Y. S.
    Zakharash, Y.
    Racz, I.
    Kull, K.
    Vcev, A.
    Faszczyk, M.
    Dilger, K.
    Greinwald, R.
    Mueller, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 313 - 322
  • [48] Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis
    Lichtenstein, Gary R.
    Kamm, Michael A.
    Boddu, Prabhakar
    Gubergrits, Natalya
    Lyne, Andrew
    Butler, Todd
    Lees, Kirstin
    Joseph, Raymond E.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 95 - 102
  • [49] CONVERT: Concurrent Once-Daily Versus Twice-Daily Radiotherapy - a phase III randomised controlled trial for patients with LS SCLC and good performance status
    Faivre-Finn, C.
    Falk, S.
    LUNG CANCER, 2011, 71 : S40 - S41
  • [50] ONCE DAILY ASACOL® IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS: A ONE-YEAR SINGE-BLIND RANDOMISED TRIAL
    Hawthorne, A. B.
    Stenson, R.
    Gillespie, D.
    Swarbrick, E. T.
    Dhar, A.
    Kapur, K. C.
    Hood, K.
    Probert, C. S.
    GUT, 2011, 60
12345